161 related articles for article (PubMed ID: 7733632)
1. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole.
Tessera L; Mucciolo E; Bertoni L; Giulotto E
Anticancer Res; 1995; 15(1):189-92. PubMed ID: 7733632
[TBL] [Abstract][Full Text] [Related]
2. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
Zieg J; Clayton CE; Ardeshir F; Giulotto E; Swyryd EA; Stark GR
Mol Cell Biol; 1983 Nov; 3(11):2089-98. PubMed ID: 6656764
[TBL] [Abstract][Full Text] [Related]
3. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
Mucciolo E; Bertoni L; Mondello C; Giulotto E
Cancer Lett; 2000 Mar; 150(2):119-27. PubMed ID: 10704733
[TBL] [Abstract][Full Text] [Related]
4. CAD overexpression in mammalian cells.
Qiu Y; Davidson JN
Adv Exp Med Biol; 1998; 431():481-5. PubMed ID: 9598115
[No Abstract] [Full Text] [Related]
5. Co-amplification of rRNA genes with CAD genes in N-(phosphonacetyl)-L-aspartate-resistant Syrian hamster cells.
Wahl GM; Vitto L; Rubnitz J
Mol Cell Biol; 1983 Nov; 3(11):2066-75. PubMed ID: 6318080
[TBL] [Abstract][Full Text] [Related]
6. Chromosome aberrations associated with CAD gene amplification in Chinese hamster cultured cells.
Ottaggio L; Agnese C; Bonatti S; Cavolina P; De Ambrosis A; Degan P; Di Leonardo A; Miele M; Randazzo R; Abbondandolo A
Mutat Res; 1988 May; 199(1):111-21. PubMed ID: 2896299
[TBL] [Abstract][Full Text] [Related]
7. The cloning and reintroduction into animal cells of a functional CAD gene, a dominant amplifiable genetic marker.
de Saint Vincent BR; Delbrück S; Eckhart W; Meinkoth J; Vitto L; Wahl G
Cell; 1981 Dec; 27(2 Pt 1):267-77. PubMed ID: 6277500
[TBL] [Abstract][Full Text] [Related]
8. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
Sharma RC; Schimke RT
Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368
[TBL] [Abstract][Full Text] [Related]
9. Induction of CAD gene amplification by restriction endonucleases in V79,B7 Chinese hamster cells.
Cavolina P; Agnese C; Maddalena A; Sciandrello G; Di Leonardo A
Mutat Res; 1989; 225(1-2):61-4. PubMed ID: 2563307
[TBL] [Abstract][Full Text] [Related]
10. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
Ardeshir F; Giulotto E; Zieg J; Brison O; Liao WS; Stark GR
Mol Cell Biol; 1983 Nov; 3(11):2076-88. PubMed ID: 6656763
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
Chan TC; Howell SB
Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification and gene deletion are induced at different rates in V79/AP4 Chinese hamster cells.
Vatteroni L; Piras A; Moretti A; Rainaldi G
Mutagenesis; 1993 Sep; 8(5):411-5. PubMed ID: 7901735
[TBL] [Abstract][Full Text] [Related]
13. Protein alterations associated with gene amplification in cultured human and rodent cells.
Conner EA; Wirth PJ
Electrophoresis; 1996 Jul; 17(7):1257-64. PubMed ID: 8855414
[TBL] [Abstract][Full Text] [Related]
14. Gene amplification in Chinese hamster DNA repair deficient mutants.
Mondello C; Riboni R; Rady M; Giulotto E; Nuzzo F
Mutat Res; 1995 Feb; 346(2):61-7. PubMed ID: 7885401
[TBL] [Abstract][Full Text] [Related]
15. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
Miele M; Bonatti S; Menichini P; Ottaggio L; Abbondandolo A
Mutat Res; 1989 May; 219(3):171-8. PubMed ID: 2567961
[TBL] [Abstract][Full Text] [Related]
16. Gene amplification in fibroblasts from ataxia telangiectasia (AT) patients and in X-ray hypersensitive AT-like Chinese hamster mutants.
Mondello C; Faravelli M; Pipitone L; Rollier A; Di Leonardo A; Giulotto E
Carcinogenesis; 2001 Jan; 22(1):141-5. PubMed ID: 11159752
[TBL] [Abstract][Full Text] [Related]
17. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
[TBL] [Abstract][Full Text] [Related]
18. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged.
Smith KA; Chernova OB; Groves RP; Stark MB; MartÃnez JL; Davidson JN; Trent JM; Patterson TE; Agarwal A; Duncan P; Agarwal ML; Stark GR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1816-21. PubMed ID: 9050862
[TBL] [Abstract][Full Text] [Related]
19. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit.
Mondello C; Rebuzzini P; Dolzan M; Edmonson S; Taccioli GE; Giulotto E
Cancer Res; 2001 Jun; 61(11):4520-5. PubMed ID: 11389084
[TBL] [Abstract][Full Text] [Related]
20. The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
Goz B; Jeffs L
J Pharmacol Exp Ther; 1994 Aug; 270(2):480-4. PubMed ID: 8071840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
